Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 23 | 2025 | 631 | 3.110 |
Why?
|
| Heart Septal Defects, Atrial | 5 | 2025 | 138 | 1.870 |
Why?
|
| Heart Defects, Congenital | 10 | 2024 | 1877 | 1.410 |
Why?
|
| Coronary Thrombosis | 3 | 2021 | 33 | 1.370 |
Why?
|
| Vascular Fistula | 3 | 2021 | 26 | 1.140 |
Why?
|
| Angioplasty, Balloon | 5 | 2024 | 123 | 1.140 |
Why?
|
| Stents | 8 | 2024 | 785 | 1.120 |
Why?
|
| Fistula | 2 | 2021 | 50 | 1.020 |
Why?
|
| Septal Occluder Device | 2 | 2023 | 52 | 0.940 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2023 | 284 | 0.900 |
Why?
|
| Treatment Outcome | 28 | 2025 | 12865 | 0.820 |
Why?
|
| Fontan Procedure | 2 | 2023 | 180 | 0.820 |
Why?
|
| Thrombolytic Therapy | 3 | 2018 | 200 | 0.780 |
Why?
|
| Pulmonary Artery | 6 | 2019 | 437 | 0.780 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2015 | 133 | 0.760 |
Why?
|
| Atrial Septum | 2 | 2025 | 21 | 0.750 |
Why?
|
| Electrocoagulation | 2 | 2023 | 31 | 0.720 |
Why?
|
| Pulmonary Veins | 4 | 2024 | 166 | 0.720 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 189 | 0.690 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2023 | 149 | 0.650 |
Why?
|
| Thrombosis | 4 | 2022 | 500 | 0.620 |
Why?
|
| Coronary Artery Disease | 4 | 2023 | 893 | 0.620 |
Why?
|
| Coronary Vessels | 5 | 2023 | 525 | 0.560 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2023 | 684 | 0.530 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 104 | 0.510 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2014 | 79 | 0.500 |
Why?
|
| Catheter Ablation | 2 | 2017 | 321 | 0.480 |
Why?
|
| Infant | 17 | 2024 | 13270 | 0.470 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 1001 | 0.450 |
Why?
|
| Pulmonary Embolism | 3 | 2024 | 192 | 0.450 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2015 | 16 | 0.440 |
Why?
|
| Foreign-Body Migration | 2 | 2014 | 64 | 0.440 |
Why?
|
| Echocardiography | 6 | 2023 | 1131 | 0.440 |
Why?
|
| Coronary Angiography | 5 | 2024 | 453 | 0.430 |
Why?
|
| Balloon Valvuloplasty | 2 | 2020 | 26 | 0.430 |
Why?
|
| Retrospective Studies | 20 | 2025 | 17557 | 0.430 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 484 | 0.420 |
Why?
|
| Hypertension, Pulmonary | 2 | 2022 | 456 | 0.410 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 417 | 0.400 |
Why?
|
| Foreign Bodies | 1 | 2014 | 96 | 0.390 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2013 | 46 | 0.390 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2013 | 26 | 0.380 |
Why?
|
| Aortic Coarctation | 1 | 2014 | 98 | 0.380 |
Why?
|
| Humans | 45 | 2025 | 130555 | 0.380 |
Why?
|
| Infant, Low Birth Weight | 1 | 2013 | 169 | 0.370 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2013 | 163 | 0.370 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2012 | 16 | 0.360 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2012 | 10 | 0.360 |
Why?
|
| Embolization, Therapeutic | 3 | 2023 | 225 | 0.360 |
Why?
|
| Time Factors | 9 | 2025 | 6215 | 0.350 |
Why?
|
| Embolism | 1 | 2012 | 38 | 0.350 |
Why?
|
| Birth Weight | 1 | 2013 | 345 | 0.350 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2017 | 113 | 0.340 |
Why?
|
| Hemodynamics | 4 | 2024 | 809 | 0.330 |
Why?
|
| Arteriovenous Fistula | 1 | 2011 | 54 | 0.320 |
Why?
|
| Down Syndrome | 1 | 2013 | 233 | 0.320 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 198 | 0.310 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2024 | 1158 | 0.310 |
Why?
|
| Child | 21 | 2024 | 26175 | 0.310 |
Why?
|
| Device Removal | 1 | 2012 | 222 | 0.310 |
Why?
|
| Vascular Surgical Procedures | 2 | 2013 | 535 | 0.300 |
Why?
|
| Electrocardiography | 2 | 2012 | 975 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2023 | 247 | 0.300 |
Why?
|
| Tachycardia, Ventricular | 1 | 2012 | 257 | 0.290 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 365 | 0.280 |
Why?
|
| Heart Failure | 2 | 2012 | 2326 | 0.280 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 100 | 0.280 |
Why?
|
| Age Factors | 6 | 2017 | 2830 | 0.270 |
Why?
|
| Adolescent | 15 | 2024 | 20774 | 0.270 |
Why?
|
| Lower Extremity | 2 | 2023 | 184 | 0.270 |
Why?
|
| Radiography, Interventional | 4 | 2017 | 78 | 0.270 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 5164 | 0.260 |
Why?
|
| Child, Preschool | 12 | 2024 | 14989 | 0.260 |
Why?
|
| Feasibility Studies | 4 | 2022 | 815 | 0.250 |
Why?
|
| Lung | 1 | 2014 | 1537 | 0.240 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8546 | 0.240 |
Why?
|
| Male | 24 | 2024 | 64534 | 0.240 |
Why?
|
| Ischemia | 2 | 2023 | 362 | 0.240 |
Why?
|
| Female | 25 | 2025 | 70425 | 0.240 |
Why?
|
| Ultrasonography, Interventional | 3 | 2018 | 207 | 0.230 |
Why?
|
| Prosthesis Design | 4 | 2021 | 623 | 0.230 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 9 | 0.220 |
Why?
|
| Splenic Vein | 1 | 2024 | 10 | 0.210 |
Why?
|
| Hepatic Veins | 1 | 2024 | 20 | 0.210 |
Why?
|
| Fetal Heart | 1 | 2025 | 132 | 0.210 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 23 | 0.210 |
Why?
|
| Myocardial Bridging | 1 | 2024 | 14 | 0.200 |
Why?
|
| Pulmonary Circulation | 3 | 2019 | 112 | 0.200 |
Why?
|
| Risk Factors | 7 | 2025 | 10967 | 0.200 |
Why?
|
| Catheters | 1 | 2023 | 81 | 0.190 |
Why?
|
| Angiography | 3 | 2024 | 181 | 0.190 |
Why?
|
| Adult | 12 | 2020 | 31157 | 0.190 |
Why?
|
| Mustard Plant | 1 | 2022 | 3 | 0.190 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 4 | 0.190 |
Why?
|
| Young Adult | 7 | 2020 | 10015 | 0.190 |
Why?
|
| Stroke | 1 | 2011 | 1060 | 0.190 |
Why?
|
| Thrombectomy | 1 | 2023 | 119 | 0.190 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2025 | 263 | 0.180 |
Why?
|
| Equipment Design | 3 | 2017 | 536 | 0.170 |
Why?
|
| Radiography | 2 | 2014 | 740 | 0.160 |
Why?
|
| Constriction, Pathologic | 3 | 2022 | 222 | 0.160 |
Why?
|
| Heart Injuries | 1 | 2020 | 49 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 309 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 59 | 0.160 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 61 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 172 | 0.150 |
Why?
|
| Palliative Care | 2 | 2014 | 446 | 0.150 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 85 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2024 | 559 | 0.150 |
Why?
|
| Everolimus | 1 | 2019 | 50 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2025 | 3678 | 0.150 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 67 | 0.140 |
Why?
|
| Ductus Arteriosus | 1 | 2019 | 60 | 0.140 |
Why?
|
| Heart | 1 | 2023 | 660 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2294 | 0.140 |
Why?
|
| Michigan | 1 | 2017 | 47 | 0.130 |
Why?
|
| Punctures | 1 | 2017 | 51 | 0.130 |
Why?
|
| Needles | 1 | 2017 | 49 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 301 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 121 | 0.130 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 413 | 0.120 |
Why?
|
| Balloon Occlusion | 1 | 2007 | 48 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2019 | 275 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 425 | 0.120 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2014 | 8 | 0.110 |
Why?
|
| Registries | 1 | 2021 | 1614 | 0.110 |
Why?
|
| Vascular Patency | 1 | 2015 | 179 | 0.110 |
Why?
|
| Middle Aged | 6 | 2017 | 28415 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 470 | 0.100 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 34 | 0.100 |
Why?
|
| Heart Septal Defects | 1 | 2014 | 42 | 0.100 |
Why?
|
| Pulmonary Atresia | 1 | 2014 | 47 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 800 | 0.100 |
Why?
|
| Aortography | 1 | 2014 | 152 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 737 | 0.100 |
Why?
|
| Bronchoscopy | 1 | 2014 | 179 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 133 | 0.100 |
Why?
|
| Emergencies | 1 | 2013 | 176 | 0.090 |
Why?
|
| Arterial Pressure | 1 | 2013 | 131 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2013 | 356 | 0.090 |
Why?
|
| Infant Mortality | 1 | 2013 | 181 | 0.090 |
Why?
|
| Systole | 1 | 2012 | 195 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 145 | 0.080 |
Why?
|
| Observer Variation | 1 | 2012 | 311 | 0.080 |
Why?
|
| Aphasia | 1 | 2011 | 14 | 0.080 |
Why?
|
| Paresis | 1 | 2011 | 32 | 0.080 |
Why?
|
| Ohio | 1 | 2011 | 85 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 194 | 0.080 |
Why?
|
| Reference Values | 1 | 2012 | 675 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 59 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2014 | 3115 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1317 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1216 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 233 | 0.080 |
Why?
|
| Linear Models | 1 | 2012 | 686 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 415 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2011 | 58 | 0.080 |
Why?
|
| Retreatment | 1 | 2009 | 86 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 114 | 0.070 |
Why?
|
| Patient Selection | 1 | 2013 | 725 | 0.070 |
Why?
|
| Texas | 1 | 2017 | 3648 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1375 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 159 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2063 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2012 | 759 | 0.060 |
Why?
|
| Disease Progression | 1 | 2013 | 2193 | 0.060 |
Why?
|
| Fluoroscopy | 2 | 2016 | 99 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 748 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2012 | 837 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3355 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 261 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 3031 | 0.050 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2024 | 60 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 3320 | 0.050 |
Why?
|
| Exercise Test | 1 | 2024 | 240 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 215 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 546 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 271 | 0.040 |
Why?
|
| Gestational Age | 1 | 2025 | 1209 | 0.040 |
Why?
|
| Prognosis | 1 | 2011 | 4867 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2023 | 357 | 0.040 |
Why?
|
| Aorta | 1 | 2023 | 522 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 29 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 108 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 338 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 713 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 782 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1154 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 655 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 371 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 219 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2024 | 6438 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7403 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 247 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3752 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 20899 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 474 | 0.020 |
Why?
|
| Critical Illness | 1 | 2014 | 622 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2901 | 0.020 |
Why?
|
| Motion | 1 | 2006 | 37 | 0.020 |
Why?
|
| Diastole | 1 | 2006 | 181 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 278 | 0.010 |
Why?
|